Shasun Pharmaceuticals, a Rs.1,000 plus pharma major from Chennai, has posted strong performance during the first quarter ended June 2012 despite foreign exchange loss of Rs.9.80 crore. Its consolidated net profit went up by 102 per cent to Rs.13.82 crore from Rs.6.83 crore. Its consolidated net sales increased by 30.1 per cent to Rs.249.99 crore from Rs.192.21 crore. Its EBDITA improved by 94 per cent to Rs.45.16 crore from Rs.23.23 crore. The employees cost increased to Rs.45.22 crore from Rs.34.26 crore, a growth of 32 per cent. Its foreign exchange loss amounted to Rs.9.80 crore as against nil in the similar period of last year.

The company's standalone net sales increased by 31.9 per cent to Rs.163.54 crore from Rs.124.01 crore. Its standalone net profit declined sharply to Rs.0.04 crore from Rs.1.26 crore on account of higher interest cost, foreign exchange loss and higher other manufacturing cost.